0001557240-14-000672.txt : 20141112 0001557240-14-000672.hdr.sgml : 20141111 20141112173027 ACCESSION NUMBER: 0001557240-14-000672 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20141112 DATE AS OF CHANGE: 20141112 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Nemus Bioscience, Inc. CENTRAL INDEX KEY: 0001516551 STANDARD INDUSTRIAL CLASSIFICATION: TRUCKING (NO LOCAL) [4213] IRS NUMBER: 450692882 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87830 FILM NUMBER: 141215410 BUSINESS ADDRESS: STREET 1: 650 TOWN CENTER DRIVE, SUITE 620 CITY: COSTA MESA STATE: CA ZIP: 92626 BUSINESS PHONE: (949) 396-0330 MAIL ADDRESS: STREET 1: 650 TOWN CENTER DRIVE, SUITE 620 CITY: COSTA MESA STATE: CA ZIP: 92626 FORMER COMPANY: FORMER CONFORMED NAME: LOAD GUARD LOGISTICS, INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: LOAD GUARD TRANSPORTATION, INC. DATE OF NAME CHANGE: 20110324 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MENDEZ FRANCISCO JAVIER CENTRAL INDEX KEY: 0001598343 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 6317 SW 16TH STREET CITY: MIAMI STATE: FL ZIP: 33155 SC 13G/A 1 fjm_13-da.htm
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549

SCHEDULE 13G/A
(Amendment No. 1)

 Under the Securities Exchange Act of 1934
 
Nemus Bioscience, Inc.
(Name of Issuer)
 
Common Stock
(Title of Class of Securities)
 
64046J100
(CUSIP Number)
 
October 31, 2014
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
 [ ] Rule 13d-1(d)
 




*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 53945E 105
(1)Names of reporting persons.
 
Francisco Mendez
 
(2) Check the appropriate box if a member of a group (see instructions)
(a)
 (b)
 
(3) SEC use only
 
(4) Citizenship or place of organization
 
United States
 
Number of shares beneficially owned by each reporting person with:
(5)Sole voting power
 
0
(6)Shared voting power
 
None
(7)Sole dispositive power
 
0
(8)Shared dispositive power
 
None
(9)Aggregate amount beneficially owned by each reporting person
 
0
 
(10)Check if the aggregate amount in Row (9) excludes certain shares (see instructions)
 
(11)Percent of class represented by amount in Row 9
 
0%
 
(12)Type of reporting person (see instructions)
 
IN
 



 
1
 
Item 1.
Item 1(a) Name of issuer:
 
Nemus Bioscience, Inc.
 
Item 1(b) Address of issuer's principal executive offices:
 
650 Town Center Drive, Suite 620, Costa Mesa, California 92626.

Item 2.

2(a) Name of person filing:
 
Francisco Mendez
 
2(b) Address or principal business office or, if none, residence:
 
6317 SW 16th Street, Miami, FL  33155
 
2(c) Citizenship:
 
American
 
2(d) Title of class of securities:
 
Common Stock
 
2(e) CUSIP No.:
 
64046J100


Item 3.


 If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
a. [ ] Broker or dealer registered under Section 15 of the Act;
b. [ ] Bank as defined in Section 3(a)(6) of the Act;
c. [ ] Insurance company as defined in Section 3(a)(19) of the Act;
d. [ ] Investment company registered under Section 8 of the Investment Company Act of 1940;
e. [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
2
f. [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

g. [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
h. [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
i. [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
j. [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
k. [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

Item 4. Ownership


 Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
a. Amount beneficially owned: 0
b. Percent of class: 0%
c. Number of shares as to which such person has:
i. Sole power to vote or to direct the vote: 0
ii. Shared power to vote or to direct the vote: 0
iii. Sole power to dispose or to direct the disposition of: 0
iv. Shared power to dispose or to direct the disposition of: 0


Item 5.


 Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ X ].
3
Item 6. Ownership of More than 5 Percent on Behalf of Another Person


Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.


Not applicable.

Item 8. Identification and Classification of Members of the Group


Not applicable.


Item 9. Notice of Dissolution of Group


Not applicable.


Item 10. Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


Signature.


 After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


 November 12, 2014


/s/ Francisco Mendez
Francisco Mendez

4